C4X Discovery Holdings (C4XD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.55p
   
  • Change Today:
    -0.20p
  • 52 Week High: 21.45
  • 52 Week Low: 7.80
  • Currency: UK Pounds
  • Shares Issued: 252.23m
  • Volume: 378,171
  • Market Cap: £21.57m

C4XD Overview

C4X Discovery (C4XD) is a pioneering Drug Discovery company, combining scientific expertise with cutting-edge technologies to efficiently deliver world‑leading medicines. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced molecular design and patient stratification capabilities, generating small molecule drug candidates across multiple disease indications focused on immuno-inflammation. We are advancing our internal portfolio which ranges from early-stage target opportunities to late-stage Drug Discovery programmes and we have two commercially partnered programmes with Sanofi and AstraZeneca, and one clinical stage candidate which has been acquired by Indivior.

1 Day Chart (18-04-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -784.4% 48.5%
ROCE n/a  
Latest F'cast
P/E n/a 1.3
PEG n/a n/a
Pr/Revenue 12.6 0.8
Pr/Book 3.3  
Latest F'cast
Revenue -36.6% 1666.1%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

C4XD Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jul-19 n/a (13.62) (18.60)p n/a n/a n/a n/a 0.0%
31-Jul-20 n/a (9.58) (8.10)p n/a n/a n/a n/a 0.0%
31-Jul-21 5.64 (5.91) (1.96)p n/a n/a n/a n/a 0.0%
31-Jul-22 2.70 (10.53) (3.57)p n/a n/a n/a n/a 0.0%
31-Jul-23 1.71 (13.42) (4.42)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

C4XD Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jul-24 30.20 14.65 6.90p 1.2 n/a n/a n/a 0.0%
31-Jul-25 6.00 (9.90) (2.80)p n/a n/a n/a n/a 0.0%
31-Jul-26 8.10 (8.20) (2.10)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

C4XD Company Announcements

Result of General Meeting 15-Apr-2024 12:37 RNS
Director/PDMR Share Purchases 09-Apr-2024 10:58 RNS
Proposed Voluntary Delisting 27-Mar-2024 07:00 RNS

C4XD ShareCast News

C4X Discovery shares soar on $11m COPD payment f... 03-Jan-2024 ShareCast
C4X Discovery launches new precision medicine pl... 22-Feb-2023 ShareCast
C4X makes positive progress with potential cance... 19-Jan-2023 ShareCast

Latest C4XD Director Deals

Traded Action Notifier PriceAmountValue
08-Apr-24 Buy Clive Dix 10.30p 485,320 £49,987.96

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

C4XD Market Data

Currency UK Pounds
Share Price 8.55p
Change Today -0.20p
% Change -2.29 %
52 Week High 21.45
52 Week Low 7.80
Volume 378,171
Shares Issued 252.23m
Market Cap £21.57m

C4XD Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.84% above the market average35.84% above the market average35.84% above the market average35.84% above the market average35.84% above the market average
1.89% below the sector average1.89% below the sector average1.89% below the sector average1.89% below the sector average1.89% below the sector average
Price Trend
81.78% below the market average81.78% below the market average81.78% below the market average81.78% below the market average81.78% below the market average
26.32% below the sector average26.32% below the sector average26.32% below the sector average26.32% below the sector average26.32% below the sector average
Income Not Available
Growth
46.95% below the market average46.95% below the market average46.95% below the market average46.95% below the market average46.95% below the market average
72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

C4XD Dividends

No dividends found

Trades for 18-Apr-2024

Time Volume / Share Price
15:21 125,000 @ 8.74p
15:44 5,000 @ 8.74p
15:29 301 @ 8.15p
14:53 5,522 @ 8.74p
14:19 791 @ 9.00p

C4XD Key Personnel

CEO Clive Dix
CFO Bradley Hoy

Top of Page